EcoDrugPlus

Cyclin D1

Ensembl ID : ENSCPOG00000032886
Gene Symbol: CCND1
4 Cross references
274 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSCPOG00000005402
Gene Symbol: CDK1
3 Cross references
243 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSCPOG00000009952
Gene Symbol: CDK2
4 Cross references
203 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSCPOG00000033131
Gene Symbol: CDK4
2 Cross references
227 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSCPOG00000004398
Gene Symbol: CDK5
2 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSCPOG00000030665
Gene Symbol: CDK6
4 Cross references
201 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSCPOG00000014671
Gene Symbol: CDK7
2 Cross references
215 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSCPOG00000010359
Gene Symbol: CDK9
3 Cross references
206 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSCPOG00000002100
Gene Symbol: CYSLTR1
2 Cross references
181 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSCPOG00000036030
Gene Symbol: CDA
2 Cross references
232 Possible Orthologues:

Cytochrome P450

Ensembl ID : ENSCPOG00000001589
Gene Symbol: CYP3A14
3 Cross references
644 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSCPOG00000022315
Gene Symbol: LOC100734717
3 Cross references
623 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).